Health justice lawyer Priti Krishtel doesn't believe your ability to heal should depend on your ability to pay. Her mission is to reform the patent system that drug companies use to block competition.

“We're not going to end the HIV epidemic until we make testing for HIV convenient and routine,” said Patrick Sullivan, lead infectious disease specialist for the Emory initiative. 

A new study suggests that. yes, there are superdodgers. But explaining why they've been able to avoid the virus is a bit complicated.

Dr. Demetre Daskalakis is steering the U.S. monkeypox response. A month into the job, he sees signs of success, but there's still more to be done.

Gilead Sciences Inc. is awarding $4.5 million in grants over the next three years to the Satcher Health Leadership Institute at Morehouse School of Medicine and Xavier University in Louisiana. The money will go toward addressing the social as well as the political determinants of health.

For years, the Centers for Disease Control and Prevention has been tracking outbreaks of HIV infections using genetic sequencing. Some are calling for this practice to stop. Sam Whitehead of Kaiser Health News’ Southern Bureau has been reporting on this. He spoke with GPB’s Peter Biello.

It's called visceral leishmaniasis. It's spread by sandflies and fatal if left untreated. Fortunately, a new drug regimen holds promise.

The ability to know your HIV status only takes minutes, which should mean good things for preventing new infections.

In mice, the HIV drug maraviroc restored a system that links new memories that are made around the same time. The finding could help treat memory problems in people.

Advocates of the proposal say it would prevent overdoses, slow the spread of HIV and inspire drug users to seek help, while proponents say safe injection sites would create an "open drug scene."

HIV remains a problem in the U.S. because people don't use life-saving prevention and treatments. COVID is heading down the same path. Here are insights from people fighting on the frontlines of HIV.

Findings from a new study help answer questions about why some people get more severe and transmissible HIV than others — and serve as a reminder that viruses don't always weaken over time.

Expanding Medicaid would give coverage to thousands of uninsured HIV patients in Georgia and provide millions of dollars of additional services for people infected with the virus, a recently released study says.

The Food and Drug Administration this week approved an injectable drug that helps prevent the spread of HIV. It only has to be taken once every eight weeks, compared to a daily oral pill.

How did this new strain of the coronavirus evolve? Researchers are investigating various possibilities. One leading theory involves ... just one person.